Nexentis Technologies (NXTS) Research & Development (2019 - 2026)
Nexentis Technologies (NXTS) posted Research & Development of $373,000 for Q2 2026, compared with $9,000 a year earlier.
Powered by 
Analysis
Nexentis Technologies (NXTS) Research & Development (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Nexentis Technologies was $532,000, up 40.4% year-over-year; for FY2025, it was $179,000, down 51.5% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of -15.6% (FY2020 to FY2025).
- In prior years, Nexentis Technologies' Research & Development was $369,000 in FY2024 (-81.0%), $1.94 million in FY2023 (+151.4%), $770,826 in FY2022 (+43.1%) and $538,684 in FY2021 (+29.2%).
- The Q2 2026 figure stands as the highest quarterly Research & Development since Q3 2023.
- On a year-over-year basis, Research & Development increased in three of the last six quarters, with growth averaging 29.2%.
- The strongest year-over-year quarter for Research & Development in the past five years was Q3 2023, with growth of 753.0%; the weakest was Q3 2024, with a decline of 98.9%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Nexentis Technologies | 1.20 Mn | -21.57 Mn | - | 373,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 373,000.00 |
| Dec 31, 2025 | 98,000.00 |
| Sep 30, 2025 | 52,000.00 |
| Jun 30, 2025 | 9,000.00 |
| Mar 31, 2025 | 20,000.00 |
| Dec 31, 2024 | 331,000.00 |
| Sep 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Mar 31, 2024 | 116,000.00 |
| Dec 31, 2023 | 109,030.00 |
| Sep 30, 2023 | 1.69 Mn |
| Jun 30, 2023 | 16,857.00 |
| Mar 31, 2023 | 118,908.00 |
| Dec 31, 2022 | 249,587.00 |
| Sep 30, 2022 | 198,501.00 |
| Jun 30, 2022 | 113,376.00 |
| Mar 31, 2022 | 209,362.00 |
| Dec 31, 2021 | 175,681.00 |
| Sep 30, 2021 | 66,470.00 |
| Jun 30, 2021 | 226,742.00 |
API Access
Nexentis Technologies Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=NXTS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "NXTS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=NXTS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();